AR

Aparna Rai

Active Director Director DIN 08679401
DIN 08679401 First appointment Jan 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Aparna Rai

Data last updated:

Aparna Rai is a Director at Pepthera Laboratories Private Limited (since 2020). The company operates in Chemicals. Pepthera Laboratories Private Limited reported revenue of ₹1.8 Lakh (FY 2025).

DIN 08679401
Primary Designation Director
Industry Chemicals
First Appointment 24 Jan 2020
Oldest Company Age 6 yrs
Largest company Pepthera Laboratories Private Limited · ₹1.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jan 20202020₹1.8 Lakh (FY 2025)Active

Board colleagues of Aparna Rai

NameDINCompanyDesignation
Gaurav Jerath08679400Pepthera Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pepthera Laboratories Private Limited
Premium access

Shareholding and investment profile for Aparna Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aparna Rai

Aparna Rai currently holds 1 directorship: Pepthera Laboratories Private Limited (Director, since 24 Jan 2020, revenue ₹1.8 Lakh (FY 2025)).

Aparna Rai was first appointed on 24 Jan 2020 as Director at Pepthera Laboratories Private Limited.

The current boards of Aparna Rai's companies include Gaurav Jerath (Pepthera Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available